13F HOLDINGS REPORT
TAKEDA PHARMACEUTICAL CO LTD
Quarter ended Q4 2024 · Filed February 13, 2025 · Accession 0001395064-25-000028
Total Value
$232.3M
Positions
15
Other Managers
1
Confidential Omitted
No
Holdings (15)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Denali Therapeutics Inc. | DNLI | 4,214,559 | $97.9M | 42.13% |
| 2 | HilleVax, Inc. | 43157M102 | 6,724,000 | $97.2M | 41.85% |
| 3 | Phathom Pharmaceuticals, Inc. | PHAT | 1,557,063 | $16.0M | 6.90% |
| 4 | Wave Life Sciences Ltd. | WVE | 1,096,892 | $5.5M | 2.36% |
| 5 | Ovid Therapeutics Inc. | OVID | 5,750,000 | $4.4M | 1.90% |
| 6 | Turnstone Biologics Corp. | 90042W100 | 895,824 | $2.3M | 1.01% |
| 7 | Shattuck Labs, Inc. | STTK | 515,619 | $2.0M | 0.86% |
| 8 | Xilio Therapeutics, Inc. | XLO | 1,475,121 | $1.4M | 0.60% |
| 9 | Ovid Therapeutics Inc. | OVID | 1,781,996 | $1.4M | 0.59% |
| 10 | Equillium, Inc. | EQ | 1,824,977 | $1.3M | 0.54% |
| 11 | Wave Life Sciences Ltd. | WVE | 250,000 | $1.2M | 0.54% |
| 12 | Rani Therapeutics Holdings, Inc. | RANI | 215,172 | $817,654 | 0.35% |
| 13 | American Well Corp | AMWL | 1,554,669 | $505,267 | 0.22% |
| 14 | Akili, Inc. | 00974B107 | 738,819 | $321,386 | 0.14% |
| 15 | STANDARD BIOTOOLS INC. | LAB | 16,515 | $29,232 | 0.01% |